Patents by Inventor Changyong Yang

Changyong Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11000518
    Abstract: A combination of a VEGFR inhibitor and a PARP inhibitor is described. In particular, this combination can be used in the preparation of a medicament for treating gastric cancer.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: May 11, 2021
    Assignee: Jiangsu Hengrui Medicine Co., Ltd.
    Inventors: Jiahua Jiang, Guoqing Cao, Changyong Yang, Lianshan Zhang, Jianjun Zou, Piaoyang Sun
  • Publication number: 20210132819
    Abstract: Techniques for managing disks involve: determining a current usage parameter associated with each of a plurality of disk sets, the current usage parameter indicating usage associated with a capability of each of the plurality of disk sets, and the capability comprising at least one of the following: a number of permitted accesses per time unit and a number of permitted writes per time unit; imbalance degree associated with the plurality of disk sets, the first imbalance degree indicating a difference in the current usage parameters of the plurality of disk sets; and causing data in at least one disk slice of a first disk set to be moved to a second disk set of the plurality of disk sets, so as to lower down the first imbalance degree. In this way, a better balance can be achieved among performances of respective disks after adjustment.
    Type: Application
    Filed: May 21, 2020
    Publication date: May 6, 2021
    Inventors: Liang Huang, Xianlong Liu, Ruipeng Yang, Xiaoliang Zhao, Changyong Yu
  • Publication number: 20210030736
    Abstract: This application describes a use of an EZH2 inhibitor combined with a BTK inhibitor in preparing a drug for treating a tumor is described.
    Type: Application
    Filed: May 17, 2018
    Publication date: February 4, 2021
    Inventors: Ke MA, Guoqing CAO, Changyong YANG, Lianshan ZHANG
  • Publication number: 20200368309
    Abstract: Disclosed is the use of a KOR agonist in combination with a MOR agonist in preparing a drug for treating pain. The KOR agonist is selected from a compound as shown in the general formula (I), and the MOR agonist is selected from a compound as shown in the general formula (II), wherein the definitions of each substituent in the general formula (I) and (II) are the same as defined in the description.
    Type: Application
    Filed: December 5, 2018
    Publication date: November 26, 2020
    Inventors: Xiaoxing HUANG, Guoqing CAO, Changyong YANG, Lianshan ZHANG
  • Publication number: 20200054764
    Abstract: The medical use of an anti-c Met antibody-cytotoxic drug conjugate is described. In particular, an anti-c-Met antibody, an antigen-binding fragment thereof, a chimeric antibody and a humanized antibody containing the anti-c-Met antibody CDRs, and an antibody-cytotoxic drug conjugate thereof or a pharmaceutically acceptable salt or solvate thereof are described. Also described are the use of a pharmaceutical composition containing the humanized anti-c-Met antibody, the antigen-binding fragment thereof, the antibody-cytotoxic drug conjugate thereof, or the pharmaceutically acceptable salt or solvate thereof as an anti-hepatoma drug.
    Type: Application
    Filed: October 13, 2017
    Publication date: February 20, 2020
    Inventors: Xing SUN, Guoqing CAO, Mi TANG, Jiahua JIANG, Changyong YANG, Lianshan ZHANG
  • Publication number: 20200054594
    Abstract: Provided are uses of the combination of a ? opioid receptor (MOR) agonist and a ? opioid receptor (KOR) agonist in the preparation of drugs for relieving and/or treating pain. The MOR agonist is selected from the compound represented in formula (I), or a tautomer, mesomer, racemate, enantiomer or diastereomer thereof, or a mixture thereof, or a pharmaceutically acceptable salt thereof. Also provided is a pharmaceutical composition containing the MOR agonist and the KOR agonist.
    Type: Application
    Filed: April 13, 2018
    Publication date: February 20, 2020
    Inventors: Zhuolu NIU, Guoqing CAO, Changyong YANG, Lianshan ZHANG
  • Publication number: 20200040078
    Abstract: Disclosed is the use of a combination of an anti-PD-1 antibody and a VEGFR inhibitor in the preparation of a drug for treating cancers.
    Type: Application
    Filed: October 9, 2017
    Publication date: February 6, 2020
    Inventors: Xing SUN, Guoqing CAO, Changyong YANG, Lianshan ZHANG, Yong GUO
  • Publication number: 20190275021
    Abstract: A combination of a VEGFR inhibitor and a PARP inhibitor is described. In particular, this combination can be used in the preparation of a medicament for treating gastric cancer.
    Type: Application
    Filed: November 30, 2017
    Publication date: September 12, 2019
    Applicants: Jiangsu Hengrui Medicine Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd.
    Inventors: Jiahua JIANG, Guoqing CAO, Changyong YANG, Lianshan ZHANG, Jianjun ZOU, Piaoyang SUN
  • Publication number: 20190224189
    Abstract: Provided is a method of treating cancer with a tyrosine-kinase inhibitor. In particular, provided is a method of treating cancer containing a mutated epidermal growth factor receptor (EGFR) with compound A, or a pharmaceutically acceptable salt thereof, preferably a maleate or dimaleate salt of compound A.
    Type: Application
    Filed: September 22, 2017
    Publication date: July 25, 2019
    Inventors: Jianjun ZOU, Yaling HUANG, Tonghuan HU, Xiaoyu ZHU, Jun FENG, Changyong YANG, Chen ZONG, Guoqing CAO
  • Patent number: 6725315
    Abstract: The present invention relates to a system and method to efficiently move data from one data bus to another data bus in a network switch. The method includes generating a packet cycle on a first data bus. The method also includes generating a control data cycle on a second data bus. The method further includes processing the packet cycle on the first data bus after processing the control data cycle on the second data bus.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: April 20, 2004
    Assignee: Nortel Networks Limited
    Inventors: Changyong Yang, Paul B. Moore
  • Patent number: 6701478
    Abstract: The present invention relates to a system and method to generate a CRC (Cyclic Redundancy Check) value using a plurality of CRC generators operating in parallel. The system includes a switching module operatively coupled to a parallel data bus. The switching module generates and places a packet cycle on the parallel data bus to transmit a data packet and packet modification commands to modify the data packet. The system further includes a bridging module operatively coupled to the parallel data bus. The bridging module modifies the data packet in accordance to the packet modification commands, and generates a Cyclic Redundancy Check (CRC) value to reflect modifications made to the data packet. The bridging module utilizes a plurality of CRC generators operating in parallel to generate the CRC value quickly and efficiently.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: March 2, 2004
    Assignee: Nortel Networks Limited
    Inventors: Changyong Yang, Paul B. Moore
  • Publication number: 20020080803
    Abstract: The present invention relates to a system and method to efficiently move data from one data bus to another data bus in a network switch. The method includes generating a packet cycle on a first data bus. The method also includes generating a control data cycle on a second data bus. The method further includes processing the packet cycle on the first data bus after processing the control data cycle on the second data bus.
    Type: Application
    Filed: December 22, 2000
    Publication date: June 27, 2002
    Inventors: Changyong Yang, Paul B. Moore